Interventional cardiologists share insights into the progress of procedures and devices such as Impella and TAVI for acute ...

An in-home foot scanner that uses artificial intelligence (AI) to recognise the warning signs of heart failure could help ...

The FDA has granted a breakthrough device designation to the BiVACOR Total Artificial Heart. Made of titanium, the device uses a magnetically levitated rotor to pump blood in adult patients with ...

Aortic valve narrowing (aortic stenosis) with concomitant cardiac amyloidosis is a severe heart disease of old age that is associated with a high risk of death. Until now, treatment has consisted of ...

Objectives General practitioners (GPs) play a key role in heart failure (HF) management. Despite multiple guidelines, the management of patients with HF in primary care is suboptimal. Therefore, all ...

Hospitalization for heart failure (HF) is associated with increased risk of death among patients with chronic HF. The degree to which hospitalization for HF is a distinct biologic entity with ...

BiVacor announced today that it received FDA breakthrough device designation for its Total Artificial Heart (TAH) system.

Heart failure (HF) is a complex syndrome with an enormous societal burden in terms of cost, morbidity, and mortality. Natriuretic peptide testing is now widely used to support diagnosis, ...

Organoids, organs-on-a-chip, and machine learning technologies have improved dramatically in recent years, but have they come ...

Hospitalized heart failure patients in the United States are living longer and receiving more optimized evidence-based care, ...

Cardiac regenerative medicine represents a promising strategy aimed at restoring impaired heart function by replacing or ...

Fewer restrictions directly benefit Nvidia, the company at the heart of a global AI infrastructure ... and applications on an American “tech stack” – a full complement of hardware and ...